Anixa Biosciences, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ANIX Nasdaq 2834 www.anixa.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anixa Biosciences, Inc.

Anixa Biosciences AGM: Shareholders Back Directors as CEO Highlights CAR-T, Vaccine Progress - Mar 13th, 2026 2:45 pm
Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast - Mar 12th, 2026 8:38 am
Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology - Mar 9th, 2026 6:30 am
Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress - Mar 2nd, 2026 7:10 am
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat - Feb 23rd, 2026 6:55 am
Anixa Biosciences CEO Calls 2026 “Pivotal” as Breast Cancer Vaccine, Ovarian CAR-T Advance - Feb 10th, 2026 1:50 pm
Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation - Feb 9th, 2026 6:00 am
Here's Why We're Not Too Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Situation - Feb 8th, 2026 5:42 am
Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization - Feb 2nd, 2026 7:00 am
Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology - Jan 27th, 2026 6:30 am
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic - Dec 15th, 2025 6:45 am
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants - Dec 11th, 2025 4:02 pm
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025 - Dec 10th, 2025 7:00 am
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization - Nov 17th, 2025 6:15 am
Top Penny Stocks To Watch In November 2025 - Nov 13th, 2025 11:05 am
Water Tower Research Issues Statement Regarding Technical Interruption During Anixa Biosciences Fireside Chat - Nov 12th, 2025 9:00 am
Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s - Nov 12th, 2025 7:00 am
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025 - Nov 10th, 2025 8:30 am
Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year? - Nov 5th, 2025 7:40 am
Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic - Nov 5th, 2025 6:55 am